(a) BAPN treatment did not affect the proliferation of MC cells, as demonstrated by MTS assay. (b) Expression of core-binding factor alpha 1/runt-related transcription factor 2 (Runx2/Cbfa1) and type I collagen α2 chain (Col1a2) did not change, while the levels of lysyl oxidase (Lox) were significantly elevated after BAPN treatment in a dose-dependent manner. (c) Collagen components were analyzed by electrophoresis. In the control, all chains (α, β, and γ) were clearly observable. However, BAPN treatment led to the inhibition of β- and γ-chain formation. Picrosirius Red staining was visualized under bright-field (d) and polarized light (e). Collagen quantity was not affected by BAPN, while the alignment of collagenous fibers and matrix maturation were impaired. Bar: 100 μm. (f) Collagen content was slightly increased following 0.5 mM BAPN treatment, but it decreased after the administration of 2 mM BAPN. Hyl/Hyp × 300 decreased after the treatment with 2 mM BAPN. Divalent DHLNL and HLNL levels decreased with 0.5 mM BAPN treatment and were not detectable following the treatment with 1.0 and 2.0 mM BAPN. Trivalent pyridinoline levels significantly decreased after the application of 0.5 mM BAPN, while they were undetectable following the treatment with 1.0 and 2.0 mM BAPN. *p < 0.05, compared to the control.</p